WeVote
Log In

Bill

Bill

HB 93

Health insurance; prohibit modifications on renewal of covered and prescribed prescription drug's contracted benefit level.

2025 Regular Session Introduced by Brent Powell

Mississippi bill would freeze prescription drug coverage levels at renewal, preventing insurers from reducing benefits for drugs patients already take, but faced cost and flexibility concerns.

Died In Committee
#insurance
0
WeVote Research Nonpartisan
Bill Summary · HB 93

Legislative bill overview

HB 93 would prohibit health insurance companies from reducing or modifying the contracted benefit level for prescription drugs that were covered and prescribed at the time of policy renewal. The bill aims to prevent situations where patients lose coverage for medications they're already taking when their insurance plan renews annually.

Why is this important

Patients relying on maintenance medications face disruption and financial hardship when insurers remove drugs from coverage at renewal, forcing them to switch medications or pay significantly more out-of-pocket. This protection would provide continuity of care and predictability for chronically ill individuals managing ongoing treatment regimens.

Potential points of contention

  • Insurance company cost concerns: Insurers argue this limits their ability to manage pharmacy costs and negotiate formularies based on changing clinical evidence and pricing. They claim it could increase premiums for all subscribers.
  • Definition ambiguity: The bill's language around "contracted benefit level" could be unclear—whether it applies to copays, deductibles, or prior authorization requirements in addition to coverage itself.
  • Market competition effects: Restrictions on formulary changes might reduce insurers' flexibility to respond to competitive pressures or cost containment strategies, potentially affecting plan innovation and pricing.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.